Skip to main content

Table 1 Clinical characteristics of the study participants

From: Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia

 

Control

PE

P-value

N

20

17

 

Age (years)

32.8 ± 5.3

30.2 ± 6.7

0.25

Pre-pregnancy BMI (kg/m2)

24.9 ± 4.9

25.2 ± 5.5

0.87

Gravidity (median, IQR)

2.5 (2–4)

2 (1–4)

ND

Parity (median, IQR)

1 (1–2)

0 (0–1)

ND

Ethniticy (Caucasian/other)

18/2

17/0

ND

SBP (T3) mmHg

118 ± 13

135 ± 18*

0.003

DBP (T3) mmHg

73 ± 9

84 ± 15*

0.01

SBP (early preg) mmHg

107 ± 8

115 ± 14

0.08

DBP (early preg) mmHg

65 ± 8

67 ± 10

0.40

Mode of delivery (VD/CS)

0/20

10/7

<0.0001

GA delivery (d)

269.6 ± 8.3

268.1 ± 10.3

0.64

Birth weight (g)

3279 ± 623

3150 ± 673

0.55

Baby gender (M/F)

10/10

9/8

ND

Glucose screen result (mmol/L)

5.76 ± 1.02

6.10 ± 1.46

0.51

  1. Results expressed as mean ± SD unless indicated otherwise; ND, not determined; VD, vaginal delivery; CS, Caesarean section; *11 of the 17 treated with anti-hypertensive agents.